Sorafenib for Residue Disease After Resection With Curative Intent (SECURE)
This study is not yet open for participant recruitment.
Verified May 2013 by Bayer
Sponsor:
Bayer
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT01751763
First received: December 14, 2012
Last updated: May 27, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | February 2015 |
| Estimated Primary Completion Date: | May 2014 (Final data collection date for primary outcome measure) |